Bruker Corporation

BRKR Healthcare Medical Devices

Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.

Revenue
+1.57%
EPS
−75.4%
Free cash flow
+278.7%
Total debt
−14.7%

Quarter to September 2026, against a year earlier

60.82 2.76 +4.75%
Market cap
$8.9B
P/E
0.0×
Fwd P/E
−412×
Dividend yield
0.34%
F-score
4/9
Altman Z
2.43
Beneish M
−2.56
Dividend safety
34/100

Bruker Corporation (BRKR) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Bruker Corporation (BRKR) trades at a EV/FCF of 38.8×. Over the past ten years it has ranged from 15.3× (February 2016) to 648× (November 2025); the current reading is higher than 50% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 128× 93.45%
FY2024 66.2× 55.93%
FY2023 42.5× (27.96%)
FY2022 58.9× 0.78%
FY2021 58.5× 80.64%
FY2020 32.4× (29.05%)
FY2019 45.6× 110.79%
FY2018 21.6× (41.45%)
FY2017 37.0× 30.25%
FY2016 28.4× 61.45%

Quarterly newest first

Period EV/FCF Change
Sep 2026 42.6× (53.25%)
Jun 2026 91.0× (1.53%)
Mar 2026 92.4× (27.81%)
Dec 2025 128× (72.64%)
43 more quarters

Against its own ten years

Low 15.3× High 648×
Ten-year median 39.0×
Current reading's percentile 45

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on BRKR